The Disparities of Coronary Artery Bypass Grafting Surgery Outcomes by Insurance Status: A Retrospective Cohort

Timothy M Connolly1, Robert S White1, Dahniel L Sastow2

  • 1Department of Anesthesiology, Weill Cornell Medicine/New York Presbyterian Hospital, 525 East 68th Street, Box 124, New York, NY, 10065, USA.

Insights

Patients with Medicaid insurance face significantly higher risks of mortality and complications after coronary artery bypass grafting (CABG) surgery compared to those with private insurance. This highlights insurance status as a key factor impacting CABG outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Health Services Research
  • Health Economics

Background:

  • Coronary artery bypass grafting (CABG) is a standard treatment for complex coronary artery disease.
  • Social determinants of health, such as insurance status, influence surgical outcomes.
  • Understanding the impact of primary payer status on CABG patients is crucial.

Purpose of the Study:

  • To investigate the association between insurance status, specifically Medicaid, and postoperative outcomes in isolated CABG patients.
  • To identify if Medicaid insurance is an independent predictor of adverse events following CABG.

Main Methods:

  • Retrospective analysis of State Inpatient Databases (2007-2014) from five states.
  • Inclusion of isolated CABG patients aged 18 years and older.
  • Multivariate regression analysis to determine adjusted odds ratios for various outcomes by insurance status.

Main Results:

  • Patients with Medicaid or Uninsured status had significantly higher adjusted odds of postsurgical inpatient mortality compared to Private Insurance.
  • Medicaid patients showed the highest adjusted odds for 30-day (OR 1.52) and 90-day (OR 1.53) readmissions.
  • Medicaid insurance was associated with increased postsurgical complications, longer length of stay, and higher total hospital charges.

Conclusions:

  • Medicaid insurance is independently associated with worse postoperative outcomes after isolated CABG.
  • Payer status, particularly Medicaid, is a significant predictor of perioperative risks in CABG surgery.
  • Further research is warranted to elucidate the underlying reasons for these disparities in outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
288